doi:10.3969/j.issn.1673-8640.2023.01.011

Abstract

CLC Number:

R378.2

Figures/Tables 4

References 7

[1]	DAVID S, REUTER S, HARRIS S R, et al. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread[J]. Nat Microbiol, 2019, 4(11):1919-1929. DOI
[2]	DURANTE-MANGONI E, ANDINI R, ZAMPINO R. Management of carbapenem-resistant Enterobacteriaceae infections[J]. Clin Microbiol Infect, 2019, 25(8):943-950. DOI URL
[3]	Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae,Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities[Z]. Geneva:WHO, 2017.
[4]	郑少微, 李萍, 张正良, 等. 2005—2017年中国CHINET常见革兰阴性菌对碳青霉烯类抗生素耐药的监测结果[J]. 临床急诊杂志, 2019, 20(1):40-44.
[5]	中国合格评定国家认可委员会. CNAS CL02 A009-2018 医学实验室质量和能力认可准则在分子诊断领域的应用说明[S]. 2018.
[6]	HU F P, GUO Y, ZHU D M, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance,2005-2014[J]. Clin Microbiol Infect, 2016, 22 (Suppl 1):S9-S14. DOI URL
[7]	ZHANEL G G, LAWRENCE C K, ADAM H, et al. Imipenem-relebactam and meropenem-vaborbactam:two novel carbapenem-β-lactamase inhibitor combinations[J]. Drugs, 2018, 78(1):65-98. DOI

基因名称	第1天			第2天			第3天			第4天			第5天			验证结果
基因名称	x	s	CV/%	x	s	CV/%	x	s	CV/%	x	s	CV/%	x	s	CV/%	验证结果
ydij	24.10	0.12	0.48	24.07	0.12	0.52	24.07	0.18	0.73	24.10	0.60	2.49	24.07	0.05	0.19	通过
NDM	31.30	0.25	0.80	31.28	0.03	0.08	31.57	0.31	0.98	31.28	0.70	2.23	31.15	0.13	0.42	通过
phoE	28.56	0.11	0.40	28.50	0.12	0.43	28.54	0.09	0.33	28.53	0.18	0.64	28.43	0.08	0.26	通过
KPC	29.23	0.14	0.49	29.14	0.09	0.31	29.23	0.17	0.57	29.04	0.14	0.48	29.11	0.19	0.66	通过

基因名称	第1天			第2天			第3天			第4天			第5天			验证结果
基因名称	x	s	CV/%	x	s	CV/%	x	s	CV/%	x	s	CV/%	x	s	CV/%	验证结果
ydij	24.10	0.12	0.48	24.07	0.12	0.52	24.07	0.18	0.73	24.10	0.60	2.49	24.07	0.05	0.19	通过
NDM	31.30	0.25	0.80	31.28	0.03	0.08	31.57	0.31	0.98	31.28	0.70	2.23	31.15	0.13	0.42	通过
phoE	28.56	0.11	0.40	28.50	0.12	0.43	28.54	0.09	0.33	28.53	0.18	0.64	28.43	0.08	0.26	通过
KPC	29.23	0.14	0.49	29.14	0.09	0.31	29.23	0.17	0.57	29.04	0.14	0.48	29.11	0.19	0.66	通过

基因名称	x	s	CV/%	验证结果
ydij	24.08	0.27	1.10	通过
NDM	31.33	0.36	1.10	通过
phoE	28.52	0.12	0.41	通过
KPC	29.15	0.16	0.53	通过

基因名称	x	s	CV/%	验证结果
ydij	24.08	0.27	1.10	通过
NDM	31.33	0.36	1.10	通过
phoE	28.52	0.12	0.41	通过
KPC	29.15	0.16	0.53	通过

样本浓度	ydij	NDM	phoE	KPC	OXA-48
1 000 拷贝/mL	34.73	33.70	31.06	31.06	31.96
	32.67	32.93	31.00	31.13	31.54
	31.85	33.15	30.86	31.55	31.51
	33.55	32.10	31.09	31.10	31.23
100 拷贝/mL	36.57	35.98	32.97	34.94	34.21
			32.71	33.13	33.43
		33.85	34.82	32.70	32.20
	37.34		33.94	32.78	32.45

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 7

Related Articles 15

Recommended Articles

Metrics

[1]	. [J]. Laboratory Medicine, 2023, 38(1): 60-65.
[2]	WANG Su, DING Li, JIANG Wenrong, MIAO Yingxin, ZHANG Yanmei, ZHAO Hu. Research progress on drug resistance and treatment strategies of hypervirulent Klebsiella pneumoniae [J]. Laboratory Medicine, 2023, 38(1): 81-86.
[3]	CHI Wenjing, DING Li, LIU Yixin, YANG Feng, LIU Tao, CONG Jianhua, GAO Zhenhui, ZHAO Hu, ZHANG Yanmei. Correlation analysis of Helicobacter pylori colonization level and metabolic syndrome in physical examination population in Shanghai [J]. Laboratory Medicine, 2022, 37(11): 1034-1038.
[4]	. [J]. Laboratory Medicine, 2022, 37(9): 901-903.
[5]	CHEN Yan, CUI Lin, HUANG Weifeng, FENG Zhengjuan, LIU Yue, XU Xuebin. Characteristics of Salmonella isolate serotyping and molecular subtyping in Panzhihua,Sichuan [J]. Laboratory Medicine, 2021, 36(11): 1125-1130.
[6]	YIN Juan, WANG Yingchao, SUI Yang, JIANG Chun, SHI Yunqi, ZHU Chaowang. Efficacy evaluation and application value of screening carbapenemase in enterobacteriaceae by mCIM and eCIM [J]. Laboratory Medicine, 2021, 36(2): 177-180.
[7]	LIU Cunfen, WANG Yan, YANG Rong, HU Lixiang. Relationship between ESBL genotyping of Escherichia coli and integron in Anning [J]. Laboratory Medicine, 2020, 35(12): 1263-1266.
[8]	ZENG Ruihuang, WANG Xiaolin, ZENG Ye, CHEN Zhixi, YUAN Ning, QIN Changhong. Roles of CA125,NLR,PLR and hs-CRP combined determination for community-acquired pneumonia with pleural effusion based on datum mining model [J]. Laboratory Medicine, 2020, 35(11): 1103-1107.
[9]	YAO Rongfeng, LI Zhi, SHEN Juying, XU Long. Dynamic analysis on the drug susceptibility of mycoplasma from urogenital tract [J]. Laboratory Medicine, 2016, 31(12): 1050-1054.
[10]	WU Rong, LÜ Yujiang, DAI Junhua, XIANG Fenfen, KONG Qianqian, QIAN Ning, ZHANG Guiliu, YANG Yuling, CHEN Lichun, KANG Xiangdong. Drug resistance of ESBLs-producing Escherichia coli to aminoglycosides and the sequences of drug resistant genes [J]. Laboratory Medicine, 2016, 31(11): 959-964.
[11]	LIU Lirong, LI Xiangyang, QU Lingna, TANG Yuxia, CAO Jinghong, YAN Xiaoping. Sensitivity of carbapenem-resistant Enterobacteriaceae with different resistant genotypes against tigecycline [J]. Laboratory Medicine, 2016, 31(5): 383-386.
[12]	YAN Wenjuan, LI Yi, WANG Shanmei, SUN Mingjie. Research on the drug resistance mechanism of carbapenem-resistant Escherichia coli [J]. Laboratory Medicine, 2016, 31(1): 56-60.
[13]	JIANG Lei, WU Fangfang, FU Chunming.. Drug resistance analysis of Escherichia coli isolated from urinary tract infection in elder patients [J]. Laboratory Medicine, 2015, 30(12): 1206-1209.
[14]	LIU Zhen, QUE Fengxia, LI Yuanyuan, WU Shuyan, HUANG Rui.. The influence of Salmonella typhi plasmid pR_ST98 on bacterial biofilm formation and virulence [J]. Laboratory Medicine, 2015, 30(10): 1033-1038.
[15]	PAN Jun, XU Qingxia, XIAO Weiqiang, CHANG Yanmin, SHEN Yong. Multilocus sequence typing study of ESBLs-producing Escherichia coli in one hospital [J]. Laboratory Medicine, 2015, 30(9): 939-943.